Angiotensin II receptor binding sites in type 1 interstitial cells in
the inner stripe of the outer medulla are readily labeled in vitro by
the radioligand but not in vivo after systemic radioligand administrat
ion. In anesthetized rats, we investigated if reduced vascular deliver
y due to angiotensin II-induced renal vasoconstriction or, alternative
ly, prior occupancy of these sites by endogenous angiotensins modulate
s angiotensin II subtype 1 receptor binding to renal medullary interst
itial cells in vivo using electron microscopic autoradiography. Using
I-125-angiotensin II, administered systemically, as a radioligand, bin
ding in control rats occurred predominantly in the glomeruli and proxi
mal tubules, while only low binding was observed in the inner stripe o
f the outer medulla. Pretreatment of rats with unlabeled [Sar(1),Ile(8
)]angiotensin II or with the angiotensin II subtype 1 receptor antagon
ist losartan before receiving the radioligand completely abolished bin
ding to all sites. Renal vasodilatation induced by sodium nitroprussid
e or use of the radiolabeled antagonist analogue I-125-[ Sar(1),Ile(8)
]angiotensin II did not alter binding to the inner stripe. In contrast
, chronic salt loading or inhibition of angiotensin-converting enzyme
by perindopril significantly increased binding not only to the cortica
l sites but also to the sites in the inner stripe of the outer medulla
. Electron microscopic autoradiographs of the inner stripe detected bi
nding in the interstitial cells only in rats treated with chronic salt
loading or perindopril. These results suggest that endogenous angiote
nsins may modulate binding of circulating angiotensin II to the inters
titial cells in vivo, and these angiotensin II receptor-bearing cells
are more likely to be more responsive to interstitial angiotensin II t
han to the circulating hormone.